Journal ArticleDOI
Renal function and cardiovascular risk in hypertensive patients.
TLDR
Data obtained in a large cohort of essential hypertensive patients are reported that reveal a significant inverse correlation between values of estimated glomerular filtration rate (GFR) at baseline and mortality due to ischaemic heart disease (IHD) during follow-up.Abstract:
During recent years, numerous studies have demonstrated the existence of a close relationship between alterations in renal function and a significant increase in cardiovascular risk in different clinical situations. The relationship appears to be particularly relevant in the hypertensive population due to the high prevalence of arterial hypertension in the general population and the frequent finding of alterations of renal function in individuals with elevated values of blood pressure [1]. Analysis of the alterations of renal function in different series of patients with arterial hypertension shows that the higher the global cardiovascular risk in a given hypertensive patient, the higher the possibility of finding the simultaneous presence of a deranged renal function [2]. In this issue of the journal, Hailpern et al. [3] report data obtained in a large cohort of essential hypertensive patients that reveal a significant inverse correlation between values of estimated glomerular filtration rate (GFR) at baseline and mortality due to ischaemic heart disease (IHD) during follow-up. Such a relationship persisted after adjustement for all known cardiovascular risk factors, and an increase of 33% in risk for mortality due to IHD was observed for each reduction in estimated GFR of 10 ml/min per 1.73 m.read more
Citations
More filters
Journal ArticleDOI
Chronic Kidney Disease and Mortality Risk: A Systematic Review
Marcello Tonelli,Natasha Wiebe,Bruce F. Culleton,Andrew A. House,Chris Rabbat,Mei Fok,Finlay A. McAlister,Amit X. Garg +7 more
TL;DR: This review supports current guidelines that identify individuals with CKD as being at high risk for cardiovascular mortality and determines which interventions best offset this risk remains a health priority.
Journal ArticleDOI
Vitamin D and chronic kidney disease
Chang Seong Kim,Soo Wan Kim +1 more
TL;DR: The altered metabolism of Vitamin D in kidney disease, and the potential renoprotective mechanisms of vitamin D in experimental and clinical studies are discussed.
Journal ArticleDOI
Hypertensive renal vascular disease and cardiovascular endpoints.
TL;DR: The development and progression of vascular disease is the primary determinant in the progressive cardiac and renal dysfunction observed in hypertension and, therefore, is the underlying mechanism of the overall clinical manifestations of cardiorenal disease.
Journal ArticleDOI
Beneficial effects of combined therapy with lacidipine and candesartan in obese hypertensive patients
TL;DR: The improvement of endothelial function due to lower level of oxidative stress and a significant decrease of immune activation has been observed in hypertensive patients with overweight and obesity under the influence of combined antihypertensive therapy with lacidipine and candesartan.
Journal ArticleDOI
Hidden chronic renal insufficiency and cardiovascular events in patients with hypertension in a primary care center
Francisco Buitrago,Juan Ignacio Calvo-Hueros,Cristina Gómez-Jiménez,Lourdes Cañón-Barroso,Félix Suárez-González,Nicolás Roberto Robles +5 more
TL;DR: The hypertensive population of 35–74 years in age with hidden CRI showed a higher incidence of cardiovascular events, buthidden CRI may not be considered an independent cardiovascular risk factor.
References
More filters
Journal ArticleDOI
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
Aram V. Chobanian,George L. Bakris,Henry R. Black,William C. Cushman,Lee A. Green,Joseph L. Izzo,Daniel W. Jones,Barry J. Materson,Suzanne Oparil,Jackson T. Wright,Edward J. Roccella +10 more
TL;DR: The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated, and empathy builds trust and is a potent motivator.
Journal ArticleDOI
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Aram V. Chobanian,George L. Bakris,Henry R. Black,William C. Cushman,Lee A. Green,Joseph L. Izzo,Daniel W. Jones,Barry J. Materson,Suzanne Oparil,Jackson T. Wright,Edward J. Roccella +10 more
TL;DR: In those older than age 50, systolic blood pressure of greater than 140 mm Hg is a more important cardiovascular disease (CVD) risk factor than diastolic BP, and hypertension will be controlled only if patients are motivated to stay on their treatment plan.
Journal ArticleDOI
The seventh report of the joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC 7 report
Aram V. Chobanian,George L. Bakris,Henry R. Black,William C. Cushman,Lee A. Green,Joseph L. Izzo,Daniel W. Jones,Barry J. Materson,Suzanne Oparil,J.T. Wright,J. R. Toccella,Edward J. Rocella,Melissa M. Brown +12 more
TL;DR: The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated, and empathy builds trust and is a potent motivator.
Proceedings ArticleDOI
2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension
Giuseppe Mancia,Enrico Agabiti Rosei,Renata Cifkova,G DeBacker,Serap Erdine,Robert Fagard,Csaba Farsang,Antony M. Heagerty,K Kawecka-Jaszcs,Wolfgang Kiowski,Sverre E. Kjeldsen,Thomas F. Lüscher,Gordon T. McInnes,Jean-Michel Mallion,Eoin O. Brien,Neil Poulter,Silvia G. Priori,Karl Heinz Rahn,Jose L. Rodicio,L. Ruilope,M. E. Safar,Jan A. Staessen,P. A. Van Zwieten,Bernard Waeber,Bryan Williams,Alberto Zanchetti,Faiez Zannad +26 more
TL;DR: The Committee has tried to avoid giving rigid rules that would constrain judgement on the management of individual patients differing in their personal, medical and cultural characteristics.
Journal ArticleDOI
Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial
TL;DR: This study examined the hypothesis that previous evidence of renal disease would independently predict future cardiovascular disease and whether ramipril continued to be effective in patients with impaired renal function, and whether the common clinical practice of withholding angiotensin-converting enzyme (ACE) inhibitors in patientsWith impaired renal excretory function is justified.
Related Papers (1)
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
Andrew S. Levey,Josef Coresh,Kline Bolton,Bruce Culleton,Kathy Schiro Harvey,T. Alp Ikizler,Cynda Ann Johnson,Annamaria T. Kausz,Paul L. Kimmel,John W. Kusek,Adeera Levin,Kenneth L. Minaker,Robert Nelson,Helmut G. Rennke,Michael Steffes,Beth Witten,Ronald J. Hogg,Susan Furth,Kevin V. Lemley,Ronald J. Portman,George Schwartz,Joseph Lau,Ethan M Balk,Ronald D. Perrone,Tauqeer Karim,Lara Rayan,Inas Al-Massry,Priscilla Chew,Brad C. Astor,Deirdre De Vine,Garabed Eknoyan,Nathan W. Levin,Sally Burrows-Hudson,William F. Keane,Alan S. Kliger,Derrick Latos,Donna Mapes,Edith Oberley,Kerry Willis,George R. Bailie,Gavin J. Becker,Jerrilynn Burrowes,David Churchill,Allan J. Collins,William Couser,Dick DeZeeuw,Alan Garber,Thomas Golper,Frank A. Gotch,Antonio M. Gotto,Joel W. Greer,Richard H. Grimm,Ramon G. Hannah,Jaime Herrera Acosta,Ronald J. Hogg,Lawrence G. Hunsicker,Michael J. Klag,Saulo Klahr,Caya Lewis,Edmund G. Lowrie,Arthur J. Matas,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith Norris,William F. Owen,Thakor G. Patel,Glenda Payne,Rosa A. Rivera-Mizzoni,David A. Smith,Robert A. Star,Theodore Steinman,Fernando Valderrábano,John Walls,Jean Pierre Wauters,Nanette Wenger,Josephine P. Briggs +78 more